20890 ⎘
Medicinal preparations containing peptides Peptides of undefined number of amino acids; Derivatives thereof
COMPOSITIONS AND USES OF LOCALLY-APPLIED ANTIMICROBIAL SYNTHETIC CATIONIC POLYPEPTIDE(S) WITH ENHANCED PERFORMANCE AND SAFETY
#2NANOPARTICLE FOR PROTEIN DELIVERY
#3METHODS FOR TREATING CANCER INCLUDING GLATIRAMER ACETATE AND IMMUNE CHECKPOINT INHIBITORS
#4METHODS AND COMPOSITIONS FOR MODIFYING MUCOUS MEMBRANES
#5OXR1 GENE THERAPY
#6GLATIRAMER DEPOT SYSTEMS FOR TREATING PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS
#7Neurotoxin Compositions with Increased Efficacy and Effect Duration
#8Compositions for Treating Pathological Calcification Conditions, and Methods Using Same
#9PROTEIN INTERFACES
#10NUTRITIONAL PRODUCT
#11MULTICOMPONENT DEGRADABLE CATIONIC POLYMERS
#12SELF-ASSEMBLING AMPHIPHILIC PEPTIDE HYDROGELS FOR TREATMENT OF NERVE INJURY
#13COMPOSITIONS AND USES OF ANTIMICROBIAL MATERIALS WITH TISSUE-COMPATIBLE PROPERTIES
#14Neural Repair Protein Composition and Preparation Method thereof and Use thereof
#15DIPEPTIDOMIMETICS AS INHIBITORS OF HUMAN IMMUNOPROTEASOMES
#16MATERIALS WITH IMPROVED PROPERTIES
#17ANTIBODIES THAT BIND HUMAN C6 AND USES THEREOF
#18CROSSLINKING AGENTS AND MEDICAL HYDROGELS FORMED THEREFROM
#19LONG LIFETIME ALPHA-HEMOLYSIN NANOPORES
#20ENGINEERED NUCLEASES THAT TARGET HUMAN AND CANINE FACTOR VIII GENES AS A TREATMENT FOR HEMOPHILIA A
#21ZINC-[GAMMA]-PGA COMPOSITIONS AND METHODS FOR TREATING CANCER
#22NANOPARTICLE DRUG TARGETING JFK AND USE THEREOF
#23Reagents and methods for treating bacterial infection
#24METHODS OF TREATING NON-BLEEDING WOUNDS, CHRONIC WOUNDS, INFLAMMATORY PAIN AND NOCICEPTIVE PAIN
#25SELF-ASSEMBLING AMPHIPHILIC PEPTIDE HYDROGELS
#26PH-RESPONSIVE LIPID DERIVATIVE
#27Activin Type 2 Receptor Binding Proteins and Methods of Making Them
#28PROTEIN CONTAINING BIO-ACTIVE COMPOSITIONS COMPRISING CELLULOSE MICROPARTICLE CARRIERS
#29COMPOSITIONS AND METHODS FOR TREATMENT OF DEMYELINATION
#30HYDROPHOBIC AURISTATIN F COMPOUNDS AND CONJUGATES THEREOF
#31Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the CNS
#32Traditional Chinese medicine mixture and traditional Chinese medicine effective ingredient compound with function of promoting directional differentiation of stem cells into cardiomyocytes, and applications thereof
#33PARATHYROID HORMONE RECEPTOR 1(PTH1R) ANTIBODIES AND USES THEREOF
#34BIOANALYTICAL ANALYSIS OF SITE-SPECIFIC ANTIBODY DRUG CONJUGATES
#35Methods and compositions for modifying mucous membranes
#36MODIFIED L-ASPARAGINASE
#37METHOD FOR PRODUCING BIOLOGIC PRODUCT VARIANTS
#38Reagents and methods for treating bacterial infection
#39BENEFITS OF SUPPLEMENTATION WITH N-ACETYLCYSTEINE AND GLYCINE TO IMPROVE GLUTATHIONE LEVELS
#40Antibodies that bind human C6 and uses thereof
#41COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS
#42GHB FORMULATION AND METHOD FOR ITS MANUFACTURE
#43METHODS OF TREATING OR PREVENTING ALZHEIMER'S DISEASE AND ASSOCIATED CONDITIONS
#44UV THERAPY PROTOCOL FOR TREATMENT OF NON-DERMATOLOGICAL CHRONIC CONDITIONS
#45Long lifetime alpha-hemolysin nanopores
#46MODIFIED ANTIBODIES
#47METHOD FOR DETECTING INFLAMMASOME PROTEINS AS BIOMARKERS OF NEUROLOGICAL DISORDERS
#48DIAGNOSIS METHODS, DIAGNOSTIC AGENTS, AND THERAPEUTIC AGENTS AGAINST ALZHEIMER'S DISEASE AND FRONTOTEMPORAL LOBAR DEGENERATION, AND SCREENING METHODS FOR THESE AGENTS
#49HDM-2 TARGETING COMPOSITIONS CAUSE TUMOR CELL NECROSIS RATHER THAN APOPTOSIS OF CANCER CELLS
#50MULTIPARAMETRIC NUCLEIC ACID OPTIMIZATION
#51UNIT FOR ANGIOGENESIS PROMOTION AND/OR NERVE REGENERATION
#52Benefits of supplementation with n-acetylcysteine and glycine to improve glutathione levels
#53USE OF TRANSFERRIN, TRANSFERRIN RECEPTOR AND ANTIBODY THEREOF IN PREPARATION OF ANTI-SARS-CoV-2 DRUG
#54Hyperproteic snack-type food product with high biological value (hbv) for patients undergoing haemodialysis
#55Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety
#56Compositions and uses of antimicrobial materials with tissue-compatible properties
#57Methods For Treating And/Or Preventing Hypersomnias
#58ANTIMICROBIAL PEPTIDE-SELENIUM NANOPARTICLES
#59IMMUNOTHERAPY FOR ANGIOGENIC DISEASE
#60Plant-derived proteoglycan and application thereof
#61Nutritional product
#62Antibacterial composition effective in treating gram negative bacterial infections and method for preparing the same
#63PROCOAGULANT COMPOUNDS
#64PLASMONICS-ACTIVE METAL NANOSTAR COMPOSITIONS AND METHODS OF USE
#65DEFERRED TREATMENT OF NERVE INJURIES
#66Compositions for treating pathological calcification conditions, and methods using same
#67METHODS FOR TREATING SEVERE ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R INHIBITOR
#68METHODS OF TREATING CERVICAL CANCER
#69Dipeptidomimetics as inhibitors of human immunoproteasomes
#70Antigen Delivery Vectors and Constructs
#71Modified L-asparaginase
#72OXR1 GENE THERAPY
#73GLATIRAMER DEPOT SYSTEMS FOR TREATING PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS
#74STABLE FORMULATIONS FOR PARENTERAL INJECTION OF PEPTIDE DRUGS
#75Reagents and methods for treating bacterial infection
#76Activin type 2 receptor binding proteins methods of making them
#77Methods of treating or preventing alzheimer's disease and associated conditions
#78DEPOT SYSTEMS COMPRISING GLATIRAMER ACETATE
#79COMPOSITIONS AND METHODS FOR THE REDUCTION OR TREATMENT OF FIBROSIS
#80Multicomponent degradable cationic polymers
#81Protein interfaces
#82Polymeric stabilizing formulations
#83Benefits of supplementation with n-acetylcysteine and glycine to improve glutathione levels
#84Methods and compositions for modifying mucous membranes
#85Long lifetime alpha-hemolysin nanopores
#86Reducing systemic regulatory T cell levels or activity for treatment of amyotrophic lateral sclerosis
#87Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cells
#88NANOPARTICLE FOR PROTEIN DELIVERY
#89Reducing systemic regulatory T cell levels or activity for treatment of amyotrophic lateral sclerosis
#90MESSENGER RNA THERAPY FOR THE TREATMENT OF FRIEDREICH'S ATAXIA
#91Method for conducing concentrated cannabis oil to be stable, emulsifiable and flavorless for use in hot beverages and resulting powderized cannabis oil
#92Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents
#93ANTIGEN BINDING COMPLEX HAVING AGONISTIC ACTIVITY AND METHODS OF USE
#94METHODS FOR TREATING INFLAMMATION
#95Aminoalcohol lipidoids and uses thereof
#96Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety
#97Antibodies that bind human C6 and uses thereof
#98Copper complexes for treatment of neurodegenerative disorders
#99Bioanalytical analysis of site-specific antibody drug conjugates
#100TREATMENTS TO ELIMINATE HIV RESERVOIRS AND REDUCE VIRAL LOAD
#101Hydrophobic Auristatin F compounds and conjugates thereof
#102MICRONEEDLE-MEDIATED DELIVERY OF TOLEROGENIC IMMUNOTHERAPEUTICS
#103METHODS AND MATERIALS FOR TREATING HUNTINGTON'S DISEASE
#104Multispecific protein drug and library thereof, preparing method therefor and application thereof
#105Methods for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using sustained release glatiramer depot systems
#106METHOD FOR DETECTING INFLAMMASOME PROTEINS AS BIOMARKERS OF NEUROLOGICAL DISORDERS
#107METHODS FOR TREATING PSORIASIS
#108Parathyroid hormone receptor 1 (PTH1R) antibodies and uses thereof
#109TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH GLATIRAMER OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
#110ENGINEERED NUCLEASES THAT TARGET HUMAN AND CANINE FACTOR VIII GENES AS A TREATMENT FOR HEMOPHILIA A
#111MULTICOMPONENT DEGRADABLE CATIONIC POLYMERS
#112Composite particles including anionic polymer and cationic polymer or peptide, and method for producing composite particles
#113COMPOSITION WITH HIGH ANTIMICROBIAL ACTIVITY AND LOW TOXICITY
#114NUCLEIC ACID PRODUCTS AND METHODS OF ADMINISTRATION THEREOF
#115Methods for treating severe atopic dermatitis by administering an IL-4R inhibitor
#116Methods for treating pseudoxanthoma elasticum (PXE)
#117Heterodimeric antibodies that bind CD3 and PSMA
#118METHOD FOR PRODUCING COMPLEX CONTAINING PROTEIN FOR MEDICAL USE AND POLYAMINO ACID, AND COMPLEX CONTAINING PROTEIN FOR MEDICAL USE AND POLYAMINO ACID
#119TUBE FEED FORMULATIONS AND METHODS FOR USING SAME
#120Proteins increasing pancreatic β cell number and methods of use
#121PUM 1 protein as target for virus inhibition
#122Treatment of multiple sclerosis with long acting glatiramer and adipose-derived stem cells
#123Compositions for treating pathological calcification conditions, and methods using same
#124NOVEL PEPTIDES AND PEPTIDOMIMETICS
#125Shear-thinning hydrogel, kit and method of preparation
#126TARGETED CONTRAST AGENTS AND METHODS FOR TARGETING CONTRAST AGENTS
#127Immunotherapy for angiogenic disease
#128PEPTIDE-BASED VACCINES, METHODS OF MANUFACTURING, AND USES THEREOF FOR INDUCING AN IMMUNE RESPONSE
#129Polymeric stabilizing formulations
#130Pharmaceutical compositions having antibacterial, antiviral, and other immunostimulatory activities
#131Immunotherapy for angiogenic disease
#132Peptide for treating ocular diseases and composition for treating ocular diseases comprising same
#133Protease assisted native-protein delivery approach (PANDA)
#134Methods of reducing neuronal injury or toxicity in epilepsy, Alzheimer's disease or Parkinson's disease using a scorpion venom heat-resistant synthetic peptide (SVHRSP)
#135A METHOD FOR PRODUCING BIOLOGIC PRODUCT VARIANTS
#136Long lifetime alpha-hemolysin nanapores
#137Shear-thinning hydrogel, kit and method of preparation
#138Methods of increasing muscle mass by administration of activin type 2 receptor antibodies
#139Drug carrier having self-assembled 3-D nucleic acid nanostructure
#140Methods for treating psoriasis
#141METHODS FOR SYSTEMICALLY DELIVERING POLYPEPTIDES AND MICROORGANISMS THEREFOR
#142UNDIFFERENTIATED STEM CELL REMOVAL AGENT AND METHOD FOR REMOVING UNDIFFERENTIATED STEM CELLS
#143COMBINATION THERAPY OF CBD AND COPAXONE
#144Procoagulant compounds
#145Nucleic acid molecules encoding muteins of human lipocalin 2 with affinity for glypican-3 (GPC3)
#146Vaccines and compositions against
#147Methods for treatment of cancer by targeting SIRT5
#148Methods of treating or preventing alzheimer's disease and associated conditions
#149Walnut oligopeptide powder, preparation method and application thereof
#150Methods to enhance microvascular engraftment of bioengineered and primary tissues
#151Zinc-[gamma]-PGA compositions and methods for treating cancer
#152Antimicrobial composition combinations comprising star shaped peptide polymers
#153Implantable meshes for controlling the movement of fluids
#154Plexin binding regulator
#155Compositions for treating pathological calcification conditions, and methods using same
#156Reagents and methods for treating bacterial infection
#157Composite particles including anionic polymer and cationic polymer or peptide, and method for producing composite particles
#158Treatments to eliminate HIV reservoirs and reduce viral load
#159PROTEIN INTERFACES
#160Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
#161Aminoalcohol lipidoids and uses thereof
#162LOW FREQUENCY GLATIRAMER ACETATE THERAPY
#163Modified L-Asparaginase
#164Copolymers including cinchona alkaloid components and one or more acrylamide or acrylate containing components, complexes containing the same, and methods of using the
#165Modified Fc molecules
#166Chemosynthetic cyclo-hepta modified peptide capable of inhibiting toxin of and use thereof
#167System and Method for Managing All Cancers by Disabling the Cancer Cells Ability to Reproduce
#168Multi-factor hair growth formulation
#169METHODS OF DOWNREGULATING TRANSLOCATED ONCOGENE EXPRESSION USING BROMODOMAIN INHIBITORS
#170Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
#171Peptide for promoting wound healing, its composition and method of using the same
#172Sleep apnea treatment
#173Method for conducing concentrated cannabis oil to be stable, emulsifiable and flavorless for use in hot beverages and resulting powderized cannabis oil
#174Method for conducing concentrated cannabis oil to be stable, emulsifiable and flavorless for use in hot beverages and resulting powderized cannabis oil
#175Method for conducing concentrated cannabis oil to be stable, emulsifiable and flavorless for use in hot beverages and resulting powderized cannabis oil
#176Method for conducing concentrated cannabis oil to be stable, emulsifiable and flavorless for use in hot beverages and resulting powderized cannabis oil
#177Method for conducing concentrated cannabis oil to be stable, emulsifiable and flavorless for use in hot beverages and resulting powderized cannabis oil
#178Method for conducing concentrated cannabis oil to be stable, emulsifiable and flavorless for use in hot beverages and resulting powderized cannabis oil
#179Method for conducing concentrated cannabis oil to be stable, emulsifiable and flavorless for use in hot beverages and resulting powderized cannabis oil
#180Programmable drug delivery profiles of tumor-targeted bacteria
#181LOW FREQUENCY GLATIRAMER ACETATE THERAPY
#182Cell penetrating peptides for intracellular delivery of molecules
#183Medicament for use in treating cardiovascular and cerebrovascular diseases
#184Treatments to eliminate HIV reservoirs and reduce viral load
#185Modified L-asparaginase
#186Methods for treating diseases related to mitochondrial stress
#187Messenger RNA therapy for the treatment of Friedreich's ataxia
#188COMPOSITIONS AND METHODS FOR INDUCING SATIETY AND TREATING NON-INSULIN DEPENDENT DIABETES MELLITUS, PRE-DIABETIC SYMPTOMS, INSULIN RESISTANCE AND RELATED DISEASE STATES AND CONDITIONS
#189Peptide having highly-shifted accumulation to pancreatic cancer cells and tissues, and use of said peptide
#190MODIFIED ANTIBODIES
#191METHODS AND COMPOSITIONS USING AMPK ACTIVATORS FOR PHARMACOLOGICAL PREVENTION OF CHRONIC PAIN
#192Strengthened t-cell modulator that can modulate the immune response, specifically designed for therapeutic use for the treatment of the disease known as vitiligo
#193Method for regulating cancer stem cell growth by inhibiting phosphorylation of 120th threonine residue of TSPYL5 protein, a composition containing the peptide sequence functioning to inhibit the phosphorylation and a use thereof
#194Method for improving recognition and/or working memory in hyperphenylalanimenia and phenylketonuria patients
#195METHOD FOR IMPROVING WHITE MATTER INTEGRITY IN HYPERPHENYLALANINEMIA AND PHENYLKETONURIA PATIENTS
#196LOW FREQUENCY GLATIRAMER ACETATE THERAPY
#197Targeting MicroRNAs for the Treatment of Fibrosis
#198Stabilized compounds having secondary structure motifs
#199Identification of cyclic peptide agonists of galanin receptor 2 and 3 guided by spexin solution structure
#200Compositions and methods related to inhibition of respiratory syncytial virus entry
#201Pharmaceutical formulations for the oral delivery of peptide drugs
#202Methods and compositions for modifying mucous membranes
#203Nucleic acid products and methods of administration thereof
#204COMBINED COMPOSITIONS FOR CONTROLLING BLOOD SUGAR LEVELS, HEPATOPROTECTION, AND FOR PREVENTION AND TREATMENT OF RELATED MEDICAL CONDITIONS
#205BROADLY NEUTRALIZING HUMAN ANTIBODY THAT RECOGNIZES THE RECEPTOR-BINDING POCKET OF INFLUENZA HEMAGGLUTININ
#206Composition and method for treatment of metabolic disorders
#207Dipeptidomimetics as inhibitors of human immunoproteasomes
#208USE OF TETRAPEPTIDE -3 GEKG OR PENTAPEPTIDE -3 GEKGF FOR TREATING DEGENERATIVE JOINT DISEASE
#209Magnetic nanoaggregate-embedded bead, manufacturing method thereof and bioparticle detection method using the same
#2104-1BB binding molecules
#211MICROFABRICATED NANOPORE DEVICE FOR SUSTAINED RELEASE OF THERAPEUTIC AGENT
#212Use of Bacteriorhodopsin as a Cosmetic and/or Therapeutic Agent in the Comprehensive Treatment of Dermatoses
#213Conotoxin peptide κ-CPTx-BTL01, preparation method therefor, and uses thereof
#214LOW FREQUENCY GLATIRAMER ACETATE THERAPY
#215Multicomponent Degradable Cationic Polymers
#216Benefits of supplementation with N-acetylcysteine and glycine to improve glutathione levels
#217Analysis of amino acid copolymer compositions
#218Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
#219Materials with improved biocompatibility
#220Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
#221Bioassimilable protein-melanin complex, preparation and uses
#222pH sensitive carrier and preparation method thereof, and pH sensitive drug and pH sensitive drug composition each containing the carrier, and method for treating or preventing diseases using the same
#223Methods for treating severe atopic dermatitis by administering an IL-4R inhibitor
#224Backbone-cyclized peptidomimetics with GLP-1R modulating activity
#225Peptide for promoting hair growth
#226Compositions for treating pathological calcification conditions, and methods using same
#227Implantable meshes for controlling the movement of fluids
#228SHEAR CONTROLLED RELEASE FOR STENOTIC LESIONS AND THROMBOLYTIC THERAPIES
#229LOW FREQUENCY GLATIRAMER ACETATE THERAPY
#230Compositions for treating pathological calcification conditions, and methods using same
#231Compositions for treating pathological calcification conditions, methods, and host cells using the same
#232Combination of IFN-gamma with Anti-ERBB Antibody for the Treatment of Cancers
#233Compositions and methods for treating symptoms associated with multiple sclerosis
#234Plasmonics-active metal nanostar compositions and methods of use
#235Methods and reagents for detecting ebola virus
#236Peptide having skin whitening activity, and use thereof
#237METHODS FOR TREATING MELANOMA
#238PROCESS FOR MANUFACTURING GLATIRAMER ACETATE PRODUCT
#239Parathyroid hormone receptor 1 (PTH1R) antibodies and uses thereof
#240Antibody which binds Lrg1 and methods of use
#241Antigen binding complex having agonistic activity and methods of use
#242Neuroprotection in Demyelinating Diseases
#243Engineered exosomes for the delivery of bioactive cargo using transmembrane tetraspanins
#244Antibodies that bind human C6 and uses thereof
#245POLYMER PARTICLES AND USES THEREOF
#246NOVEL PEPTIDES AND PEPTIDOMIMETICS
#247Lactic-acid-bacteria-containing composition, oral pharmaceutical composition for treating HPV infection and/or HPV-associated tumors, and mucosal immunity-inducing agent
#248LONG LIFETIME ALPHA-HEMOLYSIN NANOPORES
#249Methods and Compositions for Preserving the Viability of Photoreceptor Cells
#250PROCESS FOR MANUFACTURING GLATIRAMER ACETATE PRODUCT
#251BIOANALYTICAL ANALYSIS OF SITE-SPECIFIC ANTIBODY DRUG CONJUGATES
#252Protein interfaces
#253Immunotherapy for angiogenic disease
#254STAT3 and ERK signal pathway inhibitor comprising mogrosides and analogs thereof
#255MULTIPARAMETRIC NUCLEIC ACID OPTIMIZATION
#256Composition and method for affecting cytokines and NF-κB
#257Peptide for treating ocular diseases and composition for treating ocular diseases comprising same
#258Compositions for treating pathological calcification conditions, and methods using same
#259Compositions for treating pathological calcification conditions, and methods using same
#260Functionalized titanium binding peptides and implants coated with same
#261Heterodimeric antibodies that bind CD3 and PSMA
#262PROCESS FOR MANUFACTURING GLATIRAMER ACETATE PRODUCT
#263Shear-thinning hydrogel, kit and method of preparation
#264Indication of antibiotic drugs for preparation of cancer inhibition pharmaceutical composition
#265METHOD FOR INHIBITING SURVIVAL, TUMORIGENESIS AND METASTASIS OF CANCER CELLS AND/OR CANCER STEM CELLS
#266Methods of treating cervical cancer
#267Substances and methods for the use in prevention and/or treatment in Huntington's disease
#268Acid-degradable and bioerodible modified polyhydroxylated materials
#269LOW FREQUENCY GLATIRAMER ACETATE THERAPY
#270Compositions comprising fusion proteins useful for modulating an immune response
#271Proteins increasing pancreatic beta cell number and methods of use
#272VASCULAR DISRUPTION AGENTS AND USES THEREOF
#273COMPOSITIONS AND METHODS FOR LONG ACTING PROTEINS
#274Activin type 2 receptor antibodies
#275Polymeric stabilizing formulations
#276Therapeutic and research application of PDCL3
#277GLYCINE MAX CONSTRUCTS, SOY PROTEIN SEQUENCES, AND METHODS OF TREATING HEALTH CONDITIONS USING THE SAME
#278METHODS OF INCREASING LATENCY OF ANESTHETIC INDUCTION USING KETONE SUPPLEMENTATION
#279Cell penetrating peptides for intracellular delivery of molecules
#280COMPOSITIONS AND METHODS OF SELECTIVELY INHIBITING IRP1 AND TREATING INFLAMMATION
#281MATERIALS WITH IMPROVED PROPERTIES
#282Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
#283Positively charged co-polymers for use as antimicrobial agents
#284Drug combinations and methods to stimulate embryonic-like regeneration to treat diabetes and other diseases
#285Aminoalcohol lipidoids and uses thereof
#286LOW FREQUENCY GLATIRAMER ACETATE THERAPY
#287PERFORIN 2 DEFENSE AGAINST INVASIVE AND MULTIDRUG RESISTANT PATHOGENS
#288Method for conducing concentrated cannabis oil to be stable, emulsifiable and flavorless for use in hot beverages and resulting powderized cannabis oil
#289Method for conducing concentrated cannabis oil to be stable, emulsifiable and flavorless for use in hot beverages and resulting powderized cannabis oil
#290Method for conducing concentrated oil to be stable, emulsifiable and flavorless for use in hot beverages and resulting powderized oil
#291Crosslinked peptide hydrogels
#292Crosslinked peptide hydrogels
#293Crosslinked peptide hydrogels
#294Crosslinked Peptide Hydrogels
#295Diagnosis methods, diagnostic agents, and therapeutic agents against alzheimer's disease and frontotemporal lobar degeneration, and screening methods for these agents
#296Low protein infant formula with increased essential amino acids
#297Targeting peptides for directing adeno-associated viruses (AAVs)
#298Ophthalmic lens material
#299Antimicrobial preparations, methods for preparing the same and uses thereof to combat microorganisms
#300Nanoparticulate and macroparticulate formulations